|
HY-113270A-100mg
|
MedChemexpress LLC
|
(3-Carboxypropyl)trimethylammonium chloride [CAS 6249-56-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-113270A-1mL
|
MedChemexpress LLC
|
(3-Carboxypropyl)trimethylammonium chloride [CAS 6249-56-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-W010254-500mg
|
MedChemexpress LLC
|
4?-Hydroxy-2?-methylacetophenone [CAS 875-59-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-W010254-1mL
|
MedChemexpress LLC
|
4?-Hydroxy-2?-methylacetophenone [CAS 875-59-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N7516-10mg
|
MedChemexpress LLC
|
4'-Hydroxy-2,4-dimethoxychalcone [CAS 151135-64-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-N7516-5mg
|
MedChemexpress LLC
|
4'-Hydroxy-2,4-dimethoxychalcone [CAS 151135-64-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-N8377-1mg
|
MedChemexpress LLC
|
Capsiate [CAS 205687-01-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N8377-10mg
|
MedChemexpress LLC
|
Capsiate [CAS 205687-01-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N8377-5mg
|
MedChemexpress LLC
|
Capsiate [CAS 205687-01-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N1389-100mg
|
MedChemexpress LLC
|
Carmine [CAS 1390-65-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N1389-500mg
|
MedChemexpress LLC
|
Carmine [CAS 1390-65-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N7476-10mg
|
MedChemexpress LLC
|
Colominic acid (sodium salt) [CAS 70431-34-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N7476-5mg
|
MedChemexpress LLC
|
Colominic acid (sodium salt) [CAS 70431-34-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1036-100mg
|
MedChemexpress LLC
|
Decoquinate [CAS 18507-89-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1036-500mg
|
MedChemexpress LLC
|
Decoquinate [CAS 18507-89-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-139573-1mg
|
MedChemexpress LLC
|
Etavopivat [CAS 2245053-57-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-139573-10mg
|
MedChemexpress LLC
|
Etavopivat [CAS 2245053-57-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-139573-100mg
|
MedChemexpress LLC
|
Etavopivat [CAS 2245053-57-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-139573-25mg
|
MedChemexpress LLC
|
Etavopivat [CAS 2245053-57-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-139573-5mg
|
MedChemexpress LLC
|
Etavopivat [CAS 2245053-57-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-139573-50mg
|
MedChemexpress LLC
|
Etavopivat [CAS 2245053-57-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-139573-1mL
|
MedChemexpress LLC
|
Etavopivat [CAS 2245053-57-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-112328-5mg
|
MedChemexpress LLC
|
Fascaplysin [CAS 114719-57-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-N2503-1mg
|
MedChemexpress LLC
|
Ginsenoside F4 [CAS 181225-33-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-N2503-5mg
|
MedChemexpress LLC
|
Ginsenoside F4 [CAS 181225-33-2]
|
|
COVID-19-immunoregulation
|
|
